Fat Loss · 10ml × 10 vials
In plain terms: Lipo-C (no B12) is a research compound - injectable, fast-acting and well studied.
Lipo-C (no B12) is the same lipotropic backbone as Lipo-C + B12 minus the cobalamin component: methionine, inositol, choline, and L-carnitine in the standard "Lipo-C" branding. The mechanism on the liver and fat-handling side is unchanged from the B12 version. Methionine is a sulfur-containing essential amino acid that donates methyl groups via the SAMe pathway and supports phosphatidylcholine synthesis. Choline is the phospholipid building block that loads triglycerides into VLDL for export out of hepatocytes. Inositol supports cell signaling and lipid transport. L-carnitine shuttles long-chain fatty acids into mitochondria for beta-oxidation, the actual fat-burning step. The lipotropic mechanism is liver-centric, handling fat already mobilized, not appetite-centric, which is why it does not move the scale on its own.
What removing B12 changes is the felt benefit, not the lipotropic action. The energy lift most users describe from Lipo-C + B12 in the first 1-2 weeks is driven almost entirely by the B12 component (a cofactor for methionine synthase and methylmalonyl-CoA mutase that gets restored in B12-low individuals). Pull B12 out and the subjective "shot in the arm" feel disappears for most users. The objective lipotropic mechanism (liver lipid mobilization plus mitochondrial fat oxidation via carnitine) is intact. The no-B12 variant exists for the narrow but real population already saturating B12 by other routes: customers on weekly IM cyanocobalamin or hydroxocobalamin shots, customers running daily high-dose oral methylcobalamin, customers with cobalt sensitivity who get reactions to combined formulations, customers with Leber's hereditary optic neuropathy where cyanocobalamin is specifically contraindicated, and customers with polycythemia or other RBC disorders who want to avoid the erythropoietic nudge from added B12.
Typical dose ranges by experience level - educational reference. Message us and we tailor it to you.
Without B12 driving the felt benefit, beginners should not expect the same "first shot, big energy lift" that they may have heard about from Lipo-C + B12 users. The honest expectation is "no major felt difference" with objective lipotropic action happening underneath. If the customer is specifically chasing a felt benefit, this is the wrong SKU and they want LC216 instead.
This is the working dose for customers using it as a GLP-1 adjunct who already supplement B12 elsewhere. The narrative is pure metabolic support, no double-dipping on cobalamin. Twice-weekly Mon/Thu is common. Different muscle than the GLP-1 if same day.
Higher-frequency dosing matches the aesthetic clinic protocol. No additional B12 saturation concern here since there is no B12 in the vial, which is actually a real advantage for customers already on weekly IM B12 shots from another source. Pair with standalone LC600 L-Carnitine if cutting hard. Cap 3 ml in a single IM site.
Straight talk - what people actually report, and what the studies measured.
Peer-reviewed studies and clinical guidelines - tap any to read the source.
15291-9/abstract) - hepatic phospholipid synthesis after methionine/choline
Read study ↗PubMedInositol deficiency and hepatic triglyceridesrat model for inositol's role in fat transport
Read study ↗PubMedL-carnitine supplementation meta-analysis, 37 RCTs30053-X/abstract) - 1.2 kg weight loss
Read study ↗PubMedL-carnitine for weight management updated meta-analysisoverweight/obese subgroup
Read study ↗PubMedMethionine metabolism and SAMe in hepatic lipid handlingmethylation pathway support
Read study ↗Clinical guidelinesNIH ODS Choline fact sheetcholine mechanism on VLDL export
Read study ↗Aggregated sentiment from public forums & socials - real-world reports, not individual endorsements.
No characteristic B-vitamin body odor or breath smell: notable absence vs the B12 version, real selling point for some
"Lipo lumps": same SubQ-volume issue as the B12 version, fix by injecting IM
"I felt nothing": majority report for the no-B12 variant, because the felt benefit in the B12 version was the B12 doing the work. This is the expected experience, not a sign of bad product
Urine color normal: no bright yellow/orange B12 excretion
Mood lift: still reported by a minority via the methionine methylation arm, but much less pronounced without the B12 cofactor present
- Divergence: clinic marketing materials typically only sell the B12 version, so there's almost no community discussion of the no-B12 formulation specifically. The honest framing is "same lipotropic action, no felt energy lift, no smell, no urine color change." Customers expecting the LC216 experience minus the smell will be disappointed if they were…
Route: IM (intramuscular) preferred; SubQ acceptable but stings and forms lumps at >1 ml volumes (same as B12 version)
Injection site: outer thigh, glute, or deltoid for IM; abdomen/love handle for SubQ. Rotate sites because the amino blend still stings
Storage: refrigerated, multi-dose vial typically 30-60 days after first puncture; check for cloudiness or color shift. Already in solution, no recon needed
Notes: Color is pale yellow to clear rather than the pink-red of the B12 version (no cobalamin chromophore). No B-vitamin body odor or breath smell, which is one of the actual reasons some customers prefer the no-B12 variant. Inject slowly to reduce sting. 23-25g 1-1.5 inch needle for IM, 27-30g 1/2 inch for SubQ. Do not mix in the same syringe as a GLP-1; separate injections, can be same day, different sites.